SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection.
SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection.
复制标题
DOI:
10.3389/fmicb.2021.625952
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Nibbering PH
中科院分区:
文献类型:
--
作者:
Scheper H;Wubbolts JM;Verhagen JAM;de Visser AW;van der Wal RJP;Visser LG;de Boer MGJ;Nibbering PH
Prosthetic joint infection (PJI) is a severe complication of arthroplasty. Due to biofilm and persister formation current treatment strategies often fail. Therefore, innovative anti-biofilm and anti-persister agents are urgently needed. Antimicrobial peptides with their broad antibacterial activities may be such candidates. An in vitro model simulating PJI comprising of rifampicin/ciprofloxacin-exposed, mature methicillin-resistant Staphylococcus aureus (MRSA) biofilms on polystyrene plates, titanium/aluminium/niobium disks, and prosthetic joint liners were developed. Bacteria obtained from and residing within these biofilms were exposed to SAAP-148, acyldepsipeptide-4, LL-37, and pexiganan. Microcalorimetry was used to monitor the heat flow by the bacteria in these models. Daily exposure of mature biofilms to rifampicin/ciprofloxacin for 3 days resulted in a 4-log reduction of MRSA. Prolonged antibiotic exposure did not further reduce bacterial counts. Microcalorimetry confirmed the low metabolic activity of these persisters. SAAP-148 and pexiganan, but not LL-37, eliminated the persisters while ADEP4 reduced the number of persisters. SAAP-148 further eradicated persisters within antibiotics-exposed, mature biofilms on the various surfaces. To conclude, antibiotic-exposed, mature MRSA biofilms on various surfaces have been developed as in vitro models for PJI. SAAP-148 is highly effective against persisters obtained from the biofilms as well as within these models. Antibiotics-exposed, mature biofilms on relevant surfaces can be instrumental in the search for novel treatment strategies to combat biofilm-associated infections.
登录
查看更多内容
影响因子:
6.4
作者:
Shan Y;Brown Gandt A;Rowe SE;Deisinger JP;Conlon BP;Lewis K
通讯作者:
Lewis K
影响因子:
11.8
作者:
Lora-Tamayo, Jaime;Murillo, Oscar;Ariza, Javier
通讯作者:
Ariza, Javier
影响因子:
3
作者:
Nell, MJ;Tjabringa, GS;Grote, JJ
通讯作者:
Grote, JJ
影响因子:
82.9
作者:
Brötz-Oesterhelt, H;Beyer, D;Labischinski, H
通讯作者:
Labischinski, H
DOI:
10.1016/j.ijantimicag.2013.02.018
发表时间:
2013-06-01
影响因子:
10.8
作者:
Molina-Manso, Diana;del Prado, Gema;Esteban, Jaime
通讯作者:
Esteban, Jaime